• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例误诊的原始浆细胞样树突状细胞瘤经历多次复发后接受异基因造血干细胞移植的病例报告。

A misdiagnosed case of blastic plasmacytoid dendritic cell neoplasm experiencing multiple recurrences who underwent allogeneic stem cell transplantation: a case report.

机构信息

Student Research Committee, School of Medicine, Islamic Azad University of Medical Sciences, Yazd, Iran.

Department of Hematology and Oncology, Islamic Azad University, Yazd Branch, Yazd, Iran.

出版信息

J Med Case Rep. 2021 May 23;15(1):292. doi: 10.1186/s13256-021-02860-z.

DOI:10.1186/s13256-021-02860-z
PMID:34022952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8141153/
Abstract

BACKGROUND

Blastic plasmacytoid dendritic cell neoplasm represents a rare type of hematologic malignancy that often manifests itself through various skin lesions. It commonly affects the elderly male population. Lymph nodes, peripheral blood, and bone marrow involvement are the typical findings that justify its aggressive nature and dismal prognosis. On histopathological assessment, malignant cells share some similarities with blastic cells from the myeloid lineage that make immunohistochemistry staining mandatory for blastic plasmacytoid dendritic cell neoplasm diagnosis.

CASE PRESENTATION

A 35-year-old Asian man presented with cervical lymphadenopathy followed by an erythematous lesion on his left upper back. At first, the lesion was misdiagnosed as an infectious disease and made the patient receive two ineffective courses of azithromycin and clarithromycin. Six months later, besides persistent skin manifestations, he felt a cervical mass, which was misdiagnosed as follicular center cell lymphoma. Tumor recurrence following the chemoradiation questioned the diagnosis, and further pathologic assessments confirmed blastic plasmacytoid dendritic cell neoplasm. The second recurrence occurred 3 months after chemotherapy. Eventually, he received a bone marrow transplant after complete remission. However, the patient expired 3 months after transplant owing to the third recurrence and gastrointestinal graft versus host disease complications.

CONCLUSIONS

Early clinical suspicion and true pathologic diagnosis play a crucial role in patients' prognosis. Moreover, allogenic bone marrow transplant should be performed with more caution in aggressive forms of blastic plasmacytoid dendritic cell neoplasm because of transplant side effects and high risk of cancer recurrence.

摘要

背景

原始血液细胞瘤是一种罕见的血液恶性肿瘤,常以多种皮肤损伤为主要表现,常见于老年男性。其典型表现为淋巴结、外周血和骨髓累及,具有侵袭性和不良预后。在组织病理学评估中,恶性细胞与髓系来源的原始细胞具有一些相似性,因此免疫组织化学染色对于原始血液细胞瘤的诊断是必需的。

病例介绍

一名 35 岁的亚裔男性,最初表现为颈部淋巴结病,随后左背部出现红斑性皮损。起初,皮损被误诊为传染病,导致患者接受了两剂无效的阿奇霉素和克拉霉素治疗。6 个月后,除了持续的皮肤表现外,他还感到颈部肿块,被误诊为滤泡中心细胞淋巴瘤。化疗和放疗后的肿瘤复发使诊断受到质疑,进一步的病理评估证实为原始血液细胞瘤。化疗后 3 个月再次复发。最终,在完全缓解后,他接受了骨髓移植。然而,患者在移植后 3 个月因第三次复发和胃肠道移植物抗宿主病并发症去世。

结论

早期临床怀疑和准确的病理诊断对患者的预后起着至关重要的作用。此外,由于移植副作用和癌症复发的高风险,对于侵袭性原始血液细胞瘤,应更加谨慎地进行同种异体骨髓移植。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0c/8141153/4c43e0821bbd/13256_2021_2860_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0c/8141153/9e1118e016fe/13256_2021_2860_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0c/8141153/4c43e0821bbd/13256_2021_2860_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0c/8141153/9e1118e016fe/13256_2021_2860_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0c/8141153/4c43e0821bbd/13256_2021_2860_Fig2_HTML.jpg

相似文献

1
A misdiagnosed case of blastic plasmacytoid dendritic cell neoplasm experiencing multiple recurrences who underwent allogeneic stem cell transplantation: a case report.一例误诊的原始浆细胞样树突状细胞瘤经历多次复发后接受异基因造血干细胞移植的病例报告。
J Med Case Rep. 2021 May 23;15(1):292. doi: 10.1186/s13256-021-02860-z.
2
Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications.儿童的母细胞性浆细胞样树突细胞肿瘤:诊断特征和临床意义。
Haematologica. 2010 Nov;95(11):1873-9. doi: 10.3324/haematol.2010.026179. Epub 2010 Jul 27.
3
An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.一例罕见的伴有B细胞淋巴增殖性疾病的皮肤原始浆细胞样树突状细胞肿瘤。
Am J Dermatopathol. 2011 May;33(3):e31-6. doi: 10.1097/DAD.0b013e3181de9ce0.
4
A critical review of treatment modalities for blastic plasmacytoid dendritic cell neoplasm.关于原始浆细胞样树突状细胞瘤治疗方式的评论性综述。
Crit Rev Oncol Hematol. 2016 Nov;107:156-162. doi: 10.1016/j.critrevonc.2016.09.003. Epub 2016 Oct 3.
5
Usefulness of allogeneic hematopoietic stem cell transplantation in first complete remission for pediatric blastic plasmacytoid dendritic cell neoplasm with skin involvement: a case report and review of literature.异基因造血干细胞移植在伴有皮肤累及的儿童原始浆细胞样树突状细胞瘤完全缓解 1 期中的作用:病例报告及文献复习。
Pediatr Blood Cancer. 2013 Nov;60(11):E140-2. doi: 10.1002/pbc.24622. Epub 2013 Jun 20.
6
Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature.伴有中枢神经系统累及的复发/难治性原始浆细胞样树突细胞肿瘤中维奈托克的应用:一例病例报告及文献复习。
J Med Case Rep. 2021 Jun 26;15(1):326. doi: 10.1186/s13256-021-02939-7.
7
F-FDG PET/CT findings in a patient with blastic plasmacytoid dendritic cell neoplasm and post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation: a case report.18F-氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描在1例浆细胞样树突状细胞肿瘤和造血干细胞移植后移植后淋巴增殖性疾病患者中的表现:病例报告
Front Med (Lausanne). 2023 Aug 17;10:1258310. doi: 10.3389/fmed.2023.1258310. eCollection 2023.
8
Blastic plasmacytoid dendritic cell neoplasm should be treated with acute leukemia type induction chemotherapy and allogeneic stem cell transplantation in first remission.原始浆细胞样树突状细胞瘤应以急性白血病诱导化疗和缓解后异基因造血干细胞移植治疗。
Int J Hematol. 2010 Sep;92(2):398-400. doi: 10.1007/s12185-010-0655-0. Epub 2010 Aug 11.
9
A rare case of blastic plasmacytoid dendritic cell neoplasm with deletion 7q.31, in the setting of heavy pre-treatment with alkylating chemotherapy.一例罕见的伴有7q.31缺失的母细胞性浆细胞样树突状细胞瘤,处于接受大量烷化剂化疗预处理的情况下。
J Oncol Pharm Pract. 2017 Oct;23(7):552-556. doi: 10.1177/1078155216665245. Epub 2016 Aug 24.
10
[Chemotherapy Combined with Venetoclax Followed by Allo-Hematopoietic Stem Cell Transplantation for Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm].[化疗联合维奈克拉继以异基因造血干细胞移植治疗母细胞样浆细胞样树突状细胞肿瘤]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Oct;31(5):1531-1536. doi: 10.19746/j.cnki.issn.1009-2137.2023.05.044.

引用本文的文献

1
Cutaneous Manifestation of a Rare Haematological Malignancy: A Case Report of the Presentation, Diagnosis, and Management of Blastic Plasmacytoid Dendritic Cell Neoplasm.一种罕见血液系统恶性肿瘤的皮肤表现:母细胞性浆细胞样树突状细胞肿瘤的病例报告——临床表现、诊断及治疗
Cureus. 2025 Jul 9;17(7):e87604. doi: 10.7759/cureus.87604. eCollection 2025 Jul.
2
Indispensable role of immunophenotyping in diagnosing leukemic phase of blastic plasmacytoid dendritic cell neoplasm without cutaneous manifestation.免疫表型分析在诊断无皮肤表现的浆细胞样树突状细胞肿瘤白血病期的不可或缺作用。
Leuk Res Rep. 2022 Apr 25;17:100317. doi: 10.1016/j.lrr.2022.100317. eCollection 2022.

本文引用的文献

1
Impact of Mixed Chimerism on Myelofibrosis Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation.混合嵌合体对异基因造血干细胞移植后骨髓纤维化结局的影响。
Biol Blood Marrow Transplant. 2020 Dec;26(12):e301-e302. doi: 10.1016/j.bbmt.2020.09.003. Epub 2020 Sep 17.
2
Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study.母细胞样浆细胞样树突状细胞肿瘤的临床多样性与治疗方法:一项回顾性多中心研究
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):1489-1495. doi: 10.1111/jdv.16215. Epub 2020 Mar 10.
3
Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN).
治疗原始浆细胞样树突细胞肿瘤(BPDCN)中 tagraxofusp 的作用。
Expert Opin Biol Ther. 2020 Feb;20(2):115-123. doi: 10.1080/14712598.2020.1701651. Epub 2019 Dec 17.
4
Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm.母细胞性浆细胞样树突状细胞肿瘤治疗的最新进展
Ther Adv Hematol. 2019 Sep 23;10:2040620719874733. doi: 10.1177/2040620719874733. eCollection 2019.
5
Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm.Tagraxofusp,首个靶向 CD123 的治疗药物,也是首个用于治疗原始浆细胞样树突状细胞瘤的靶向药物。
Expert Rev Clin Pharmacol. 2019 Oct;12(10):941-946. doi: 10.1080/17512433.2019.1662297. Epub 2019 Oct 1.
6
Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects.母细胞性浆细胞样树突状细胞肿瘤:挑战与未来前景
Blood Lymphat Cancer. 2017 Dec 11;7:85-93. doi: 10.2147/BLCTT.S132060. eCollection 2017.
7
Blastic plasmacytoid dendritic cell neoplasm in the background of myeloproliferative disorder and chronic lymphocytic leukaemia.骨髓增殖性疾病和慢性淋巴细胞白血病背景下的母细胞性浆细胞样树突状细胞肿瘤
BMJ Case Rep. 2019 Jul 15;12(7):e230332. doi: 10.1136/bcr-2019-230332.
8
Treatment advances in blastic plasmacytoid dendritic cell neoplasm.母细胞样浆细胞样树突状细胞肿瘤的治疗进展
Clin Adv Hematol Oncol. 2019 Apr;17(4):207-209.
9
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.塔拉唑滨治疗原始浆细胞样树突状细胞瘤。
N Engl J Med. 2019 Apr 25;380(17):1628-1637. doi: 10.1056/NEJMoa1815105.
10
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report.母细胞性浆细胞样树突状细胞肿瘤:一例报告
Acta Derm Venereol. 2019 Apr 1;99(4):456-457. doi: 10.2340/00015555-3141.